InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2018-06-07 | Richard W. Allen(R-GA12) | house | Sale | $1,001 - $15,000 |
No financial data available for BAYZF.
Company may not file with SEC or CIK is unresolved.
Assessing Bayer (XTRA:BAYN) Valuation After New OCEANIC STROKE Phase III Asundexian Data Spotlight
Bayer Faces Roundup Ruling And Stroke Trial Data With Undervalued Shares
FDA said to have named Katherine Szarama as acting CBER chief
Microsoft says it has over 20M paid Copilot users, and they really are using it
Regeneron Slumps On An Unexpected Setback For Its Bread-And-Butter Drug
Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD Strength
Regeneron Pharmaceuticals: Q1 Beat Driven By Dupixent And Eylea HD Strength
Regeneron shares slide despite Q1 beat
Regeneron drops despite Q1 beat, $3B share buyback program
Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian
New Study Highlights Societal Optimism Toward Breakthrough Science, and Rising Anxiety About How Fast the World Is Changing
Bayer Aktiengesellschaft (BAYRY) Shareholder/Analyst Call Transcript